Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focusing on the development of innovative biological therapies designed to selectively modulate the human immune system. Its pioneering approach aims to address a wide range of unmet medical needs in oncology, chronic infectious diseases, and autoimmune disorders. By leveraging its proprietary Immune Modulation platform, Cue Biopharma seeks to enhance patient outcomes and improve the efficacy of cancer immunotherapies, positioning itself as a key player in the evolving landscape of immuno-oncology.
Click "Analyze" to generate stock analysis
CUE Price Trend and Signals
CUE Option Volumes & Open Interests (aggregated)
CUE Put Call Ratios and IV (aggregated)
CUE Financials
2025-10-29Somewhat Bearishprice_signal
Monthly low detected.
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.